PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32029037-8	2019	Compared with the LPS group, the oxidative activities and inflammatory factors above were inhibited in EP group [MDA (mumol/L): 12.35+-2.21 vs. 45.95+-1.76, SOD (kU/L): 54.68+-1.42 vs. 40.73+-1.60, IL-6 (ng/L): 67.87+-2.61 vs. 338.92+-20.91, TNF-alpha (ng/L): 19.23+-1.80 vs. 180.69+-6.51], mitochondrial membrane potential and ATP level were significantly increased [mitochondrial membrane potential: (99.43+-0.25)% vs. (69.40+-0.75)%, ATP (x106 RLU): 0.19+-0.01 vs. 0.12+-0.05], the expression of mitochondrial fission protein was significantly decreased (DAPK-2/beta-actin: 0.03+-0.01 vs. 0.61+-0.02), mitochondrial fusion proteins were significantly increased (Mfn-1/beta-actin: 0.43+-0.04 vs. 0.17+-0.01, Mfn-2/beta-actin: 0.201+-0.004 vs. 0.001+-0.001), percentage of cell apoptosis was significantly decreased [(5.25+-0.17)% vs. (34.42+-0.64)%], the expressions of apoptotic proteins were significantly decreased (caspase-3/beta-actin: 0.25+-0.15 vs. 1.76+-0.01, caspase-9/beta-actin: 0.09+-0.02 vs. 1.52+-0.12, Cyt C/beta-actin: 0.001+-0.001 vs. 0.350+-0.030), and the expressions of anti-apoptotic proteins and PARP were significantly increased (Bcl-2/beta-actin: 0.500+-0.010 vs. 0.009+-0.004, Bcl-xL/beta-actin: 0.550+-0.010 vs. 0.009+-0.001, PARP/beta-actin: 0.94+-0.01 vs. 0.16+-0.13), with statistically significant differences (all P < 0.05).	ethyl pyruvate	103-105	BCL2 like 1	Homo sapiens	1204-1210